Avantor Revenue 2018-2025 | AVTR
Avantor annual/quarterly revenue history and growth rate from 2018 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Avantor revenue for the quarter ending June 30, 2025 was $1.683B, a 1.14% decline year-over-year.
- Avantor revenue for the twelve months ending June 30, 2025 was $6.666B, a 2.34% decline year-over-year.
- Avantor annual revenue for 2024 was $6.784B, a 2.64% decline from 2023.
- Avantor annual revenue for 2023 was $6.967B, a 7.26% decline from 2022.
- Avantor annual revenue for 2022 was $7.512B, a 1.71% increase from 2021.
| Avantor Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $6,784 |
| 2023 | $6,967 |
| 2022 | $7,512 |
| 2021 | $7,386 |
| 2020 | $6,394 |
| 2019 | $6,040 |
| 2018 | $5,864 |
| 2017 | $1,247 |
| Avantor Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-06-30 | $1,683 |
| 2025-03-31 | $1,581 |
| 2024-12-31 | $1,687 |
| 2024-09-30 | $1,714 |
| 2024-06-30 | $1,703 |
| 2024-03-31 | $1,680 |
| 2023-12-31 | $1,723 |
| 2023-09-30 | $1,720 |
| 2023-06-30 | $1,744 |
| 2023-03-31 | $1,780 |
| 2022-12-31 | $1,795 |
| 2022-09-30 | $1,857 |
| 2022-06-30 | $1,911 |
| 2022-03-31 | $1,950 |
| 2021-12-31 | $1,908 |
| 2021-09-30 | $1,834 |
| 2021-06-30 | $1,859 |
| 2021-03-31 | $1,786 |
| 2020-12-31 | $1,791 |
| 2020-09-30 | $1,605 |
| 2020-06-30 | $1,479 |
| 2020-03-31 | $1,519 |
| 2019-12-31 | $1,524 |
| 2019-09-30 | $1,504 |
| 2019-06-30 | $1,532 |
| 2019-03-31 | $1,480 |
| 2018-12-31 | |
| 2018-09-30 | $1,494 |
| 2018-06-30 | $1,478 |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $8.781B | $6.784B |
| Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $151.373B | 28.07 |
| CVS Health (CVS) | United States | $89.823B | 11.17 |
| Elevance Health (ELV) | United States | $69.805B | 9.39 |
| Cencora (COR) | United States | $58.879B | 19.61 |
| DiDi Global (DIDIY) | China | $28.380B | 30.15 |
| Labcorp Holdings (LH) | United States | $23.110B | 18.37 |
| Natera (NTRA) | United States | $22.048B | 0.00 |
| BioMerieux (BMXMF) | France | $17.636B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.729B | 0.00 |
| ICON (ICLR) | Ireland | $14.556B | 14.01 |
| Medpace Holdings (MEDP) | United States | $13.083B | 34.63 |
| Solventum (SOLV) | United States | $12.631B | 13.03 |
| CochLear (CHEOY) | Australia | $12.527B | 0.00 |
| Viatris (VTRS) | United States | $12.417B | 4.42 |
| Revvity (RVTY) | United States | $10.644B | 18.75 |
| Caris Life Sciences,�Inc (CAI) | United States | $9.863B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $9.237B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.854B | 14.90 |
| HealthEquity (HQY) | United States | $7.700B | 33.73 |
| Bausch + Lomb (BLCO) | Canada | $5.147B | 34.62 |
| Sotera Health (SHC) | United States | $4.630B | 25.87 |
| BrightSpring Health Services (BTSG) | United States | $4.186B | 31.93 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.455B | 79.14 |
| Surgery Partners (SGRY) | United States | $3.057B | 38.45 |
| Alignment Healthcare (ALHC) | United States | $2.974B | 0.00 |
| Concentras Parent (CON) | United States | $2.966B | 18.81 |
| Organon (OGN) | United States | $2.436B | 2.65 |
| Premier (PINC) | United States | $2.104B | 19.50 |
| Progyny (PGNY) | United States | $1.940B | 41.02 |
| Ardent Health (ARDT) | United States | $1.863B | 7.19 |
| PACS (PACS) | United States | $1.817B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.518B | 25.71 |
| Pediatrix Medical (MD) | United States | $1.417B | 9.46 |
| Teladoc Health (TDOC) | United States | $1.276B | 0.00 |
| Omada Health (OMDA) | $1.240B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.132B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.812B | 4.76 |
| AMN Healthcare Services Inc (AMN) | United States | $0.778B | 9.62 |
| CareDx (CDNA) | United States | $0.648B | 11.93 |
| Performant Healthcare (PHLT) | United States | $0.602B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.598B | 102.50 |
| Nutex Health (NUTX) | United States | $0.515B | 7.80 |
| Agilon Health (AGL) | United States | $0.501B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.482B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.471B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.467B | 7.01 |
| SBC Medicals (SBC) | United States | $0.413B | 9.07 |
| So-Young (SY) | China | $0.412B | 0.00 |
| Enhabit (EHAB) | United States | $0.411B | 27.03 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.391B | 0.00 |
| Oncology Institute (TOI) | United States | $0.334B | 0.00 |
| LifeMD (LFMD) | United States | $0.294B | 0.00 |
| Beauty Health (SKIN) | United States | $0.269B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.184B | 0.00 |
| DocGo (DCGO) | United States | $0.157B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.116B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.085B | 0.00 |
| KindlyMD (NAKA) | United States | $0.076B | 0.00 |
| Biodesix (BDSX) | United States | $0.060B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.050B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.036B | 0.00 |
| ModivCare (MODV) | United States | $0.027B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.011B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |